Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/557"

Predicate	Value (sorted: default)
rdfs:label	"evidence_1434"
rdf:type	?:Evidence ?:Item
?:Evidence_enzyme_system	""
?:Evidence_type	?:Non_Tracable_Statement
?:content	"The FDA guidance considers (S)-mephenytoin 4-hydroxylation to be catalyzed selectively by CYP2C19 in vitro (see Table 3 of page 32) and lists it as a 'sensitive' CYP2C19 substrate in vivo (see Table 4 page 21)"
dc:creator	"boycer"
dc:date	"06/17/2009 13:15:05"
rdfs:seeAlso	?:FDA-Guidance-Drug-Interaction-Studies%E2%80%93Study%20Design-Data-Analysis-and-Implications-2006.pdf

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl

The resource appears as object in one triple:

{ mephenytoin_in_viVo_probe_substrate_of_enzyme_cyp2c19, <http://purl.org/swan/1.2/swan-commons#citesAsSupportingEvidence>, evidence_1434 }

Context graph